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Trophoblast giant cells (TGCs) are the first terminally differentiated subtype to form in the trophoblast cell lineage in rodents. In addition to
mediating implantation, they are the main endocrine cells of the placenta, producing several hormones which regulate the maternal endocrine and
immune systems and promote maternal blood flow to the implantation site. Generally considered a homogeneous population, TGCs have been
identified by their expression of genes encoding placental lactogen 1 or proliferin. In the present study, we have identified a number of TGC
subtypes, based on morphology and molecular criteria and demonstrated a previously underappreciated diversity of TGCs. In addition to TGCs
that surround the implantation site and form the interface with the maternal deciduas, we demonstrate at least three other unique TGC subtypes:
spiral artery-associated TGCs, maternal blood canal-associated TGCs and a TGC within the sinusoidal spaces of the labyrinth layer of the
placenta. All four TGC subtypes could be identified based on the expression patterns of four genes: Pl1, Pl2, Plf (encoded by genes of the
prolactin/prolactin-like protein/placental lactogen gene locus), and Ctsq (from a placental-specific cathepsin gene locus). Each of these subtypes
was detected in differentiated trophoblast stem cell cultures and can be differentially regulated; treatment with retinoic acid induces Pl1/Plf +
TGCs preferentially. Furthermore, cell lineage tracing studies indicated unique origins for different TGC subtypes, in contrast with previous
suggestions that secondary TGCs all arise from Tpbpa+ ectoplacental cone precursors.
© 2007 Elsevier Inc. All rights reserved.Keywords: Murine placenta; Trophoblast; Trophoblast giant cell; Retinoic acidIntroduction
The placenta is composed of a variety of differentiated
epithelial cell types (trophoblast) each having specialized
functions during pregnancy. The trophoblast lineage is best
understood in mice and is derived from the trophectoderm,
which forms at the blastocyst stage of development. The
trophectoderm forms an outer shell of cells surrounding the
inner cell mass. After implantation, trophectoderm cells not in
direct contact with the inner cell mass, the mural trophectoderm,
stop dividing and differentiate to form trophoblast giant cells
(TGCs) which line the implantation chamber, anastomosing to
form a diffuse network of blood sinuses for the early transport
and exchange of nutrients and endocrine signals (Bevilacqua⁎ Corresponding author. Fax: +1 403 270 0737.
E-mail address: jcross@ucalgary.ca (J.C. Cross).
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doi:10.1016/j.ydbio.2007.01.009and Abrahamsohn, 1988). In contrast, the trophectoderm
immediately overlying the inner cell mass, the polar trophecto-
derm, continues to proliferate and gives rise to all the remaining
trophoblast cell types of the placenta (Cross et al., 1994),
including spongiotrophoblast, glycogen trophoblast cells,
several labyrinth trophoblast cell types, and a later wave of
TGCs (called ‘secondary’ to distinguish them from the initial
‘primary’ group) (Simmons and Cross, 2005). Secondary TGCs
are thought to derive from the differentiation of ectoplacental
cone precursors, since cultured trophoblast stem cells first pass
through a progenitor phase characterized by the expression of
Mash2 and Tpbpa (markers of ectoplacental cone) before
expressing TGC-specific genes (Carney et al., 1993; Scott et al.,
2000).
TGCs are large, highly polyploid cells that form through the
process of endoreduplication (Gardner and Davies, 1993;
MacAuley et al., 1998). They are inherently invasive and
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conceptus into the maternal decidua (Zybina et al., 2000). In
addition, they produce paracrine and endocrine factors including
angiogenic factors (Lee et al., 1988; Carney et al., 1993; Voss
et al., 2000), vasodilators (Yotsumoto et al., 1998; Gagioti et al.,
2000), and anticoagulants (Weiler-Guettler et al., 1996),
presumably to promote blood flow to the implantation site,
luteotrophic and lactogenic hormones to influence maternal
responses to pregnancy (Linzer and Fisher, 1999; Cross et al.,
2002), and interferon that affects the differentiation of decidual
stromal cells (Bany and Cross, 2006). Terminally differentiated
TGCs express several members of the prolactin/placental
lactogen gene family (Wiemers et al., 2003), including placental
lactogen 1 (Pl1/Csh1), placental lactogen 2 (Pl2/Csh2), and
proliferin (Plf) (Lee et al., 1988; Faria et al., 1990, 1991;
Yamaguchi et al., 1992, 1994; Carney et al., 1993; Hamlin et al.,
1994), genes widely used as markers of TGCs. In addition,
TGCs also express members of the cathepsin gene family that
are clustered on mouse chromosome 13 (Hemberger et al., 2000;
Ishida et al., 2004) which, like the prolactin/placental lactogen
gene locus (Wiemers et al., 2003), represents a rodent-specific
expansion of genes that appear to be exclusively expressed in the
placenta (Deussing et al., 2002; Sol-Church et al., 2002).
Differentiation of TGCs is often considered a “default
pathway” as factors which promote trophoblast stem cell self-
renewal such as FGF, Nodal, Activin, and TGFβ actively
suppress TGC formation and withdrawal of these factors
results in rapid differentiation into TGCs (Tanaka et al., 1998;
Erlebacher et al., 2004; Guzman-Ayala et al., 2004; Hughes
et al., 2004). Despite this, numerous exogenous factors such
as retinoic acid (RA) (Yan et al., 2001; Hemberger et al.,
2004), diethylstilbestrol (DES) (Tremblay et al., 2001),
parathyroid hormone-related protein (PTHrP) (El-Hashash
et al., 2005), and nerve growth factor (NGF) (Kanai-Azuma
et al., 1997) have all been shown to promote TGC formation.
Whether these paracrine or endocrine factors are required in
vivo is unclear. The Hand1 transcription factor is required for
TGC differentiation as Hand1 deficient conceptuses die
between embryonic day (E) 7.5 and 8.5 due to a block in
TGC formation (Riley et al., 1998; Scott et al., 2000). Hand1
appears to be required for both primary and secondary TGC
differentiation since there are fewer trophoblast cells lining
the implantation site and the ones that are present are smaller
than normal and have reduced expression of TGC-specific
genes (Scott et al., 2000). In vitro, Hand1 mutant trophoblast
cells are also less invasive (Hemberger et al., 2004).
Recent observations indicate that TGCs may not be a
homogeneous population. For example, detailed studies of the
uterine vasculature during gestation identified Plf-positive/Pl1-
negative trophoblast cells which have replaced the maternal
endothelial cells in the lumen of the spiral arteries (Adamson
et al., 2002; Cross et al., 2002; Hemberger et al., 2003).
Interestingly, the endovascular trophoblast cells express only Plf
and not Pl1, even at a time when Pl1 is still strongly expressed in
TGCs at the barrier between the decidua and ectoplacental cone,
indicating that there may be more than one type of TGC. In
further support of this idea, there have been several reports ofcells that express Pl2, as well as several cathepsin genes, within
the labyrinth layer of the placenta during the second half of
gestation (Campbell et al., 1989; Deb et al., 1991; Dai et al.,
2000; Sahgal et al., 2000; Lee et al., 2003; Ishida et al., 2004;
Simmons and Cross, 2005). These cells appear to be different
than the TGCs lining the implantation site and invading spiral
arteries because, while they express Pl2, they never express Pl1
or Plf. Together these observations suggest the existence of
several TGCs subtypes within the murine placenta. In the course
of further studying the mouse placenta in detail, we have indeed
characterized new subtypes of TGCs. Based on characteristic
cell morphologies, ploidy analysis, localization, and differential
expression of genes (Pl1, Pl2, Plf, and Ctsq), we have
distinguished four TGC subtypes both in vivo and in vitro.
Using cell lineage tracing, we have found that the TGC subtypes
have different developmental origins.
Materials and methods
Animals
For wild-type conceptuses, CD1 mice (Charles River) were crossed and
pregnant females dissected at E8.5 through E18.5 (noon of the day of vaginal
plug is designated E0.5). For cell lineage tracing studies, Tpbpa-Cre-GFP
female mice (Fortier et al., submitted for publication) were crossed with male
Z/AP mice (Lobe et al., 1999) and pregnant females were dissected at E14.5.
Briefly, Tpbpa-Cre-GFP mice were constructed by placing a Cre recombinase-
IRES-EGFP cassette downstream of 5.4 kb of the Tpbpa promoter (Calzonetti et
al., 1995). The construct was then used to generate transgenic mice via
pronuclear injection. Three lines were generated which produced similar
temporal and spatial expression of Cre-EGFP in accordance with endogenous
Tpbpa. Line 5 was used for our studies because it displayed the earliest onset
of expression (∼E8.0) which coincides with the onset of endogenous expression
(Calzonetti et al., 1995). Expression at this time is restricted to the tip of the
ectoplacental cone but later is detectable throughout the spongiotrophoblast. Cre
recombinase activity was also detectable as early as E8 (Fortier et al., submitted
for publication). All animals were housed under normal light conditions (12 h
light/12 h dark) with free access to food and water. All animal procedures were
carried out in accordance with the University of Calgary Animal Care
Committee.
Cell culture
Trophoblast stem (TS) cells (tgRs26 provided by Tilo Kunath and Janet
Rossant) were grown as previously described (Tanaka et al., 1998; Hughes et al.,
2004) at 37 °C under 95% air and 5% CO2. TS cell medium contained 20% fetal
bovine serum (CanSera), 1 mM sodium pyruvate (Invitrogen), 50 μg/ml
penicillin/streptomycin, 5.5×10−5 M β-mercaptoethanol (Invitrogen), 25 ng/ml
basic fibroblast growth factor (Sigma), and 1 μg/ml heparin (Fisher Scientific) in
RPMI 1640 (Invitrogen), with 70% of the medium being preconditioned by
incubating on embryonic fibroblasts for 48 h. Differentiating medium consisted
of the TS medium but without basic fibroblast growth factor, heparin, or
embryonic fibroblast preconditioning. Hand1 heterozygous and homozygous
mutant TS cells were cultured under the same conditions as tgRs26 TS cells and
their generation has been previously described (Hemberger et al., 2004). In some
experiments, retinoic acid (RA, Sigma) was dissolved in ethanol and added to
TS medium to a final concentration of 5 μM (RA), ethanol only was used as a
control.
RNA isolation and northern blot analysis
Total RNA was collected from ectoplacental cone plus chorion tissues at
E8.5 and E9.5 and placentas from E10.5 through E18.5 by homogenization in
Trizol Reagent (Invitrogen), following the manufacturer's instructions. Total
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column (Qiagen) per well of a six-well plate following the manufacturer's
instructions. Ten micrograms of total RNA was separated on a 1.1%
formaldehyde agarose gel, blotted onto GeneScreen nylon membrane (Perkin
Elmer), and UV cross-linked. Random-primed DNA labeling of cDNA probes
for Pl1, Pl2, Plf, and Ctsq was carried out with 25 μCi 32P-dCTP and isolated
on Sephadex G-50 columns (AmershamBiosciences). Hybridizations were done
at 60 °C overnight in hybridization buffer as previously described (Church and
Gilbert, 1984). Signals were detected by exposure to BioMax MR film (Kodak)
at −80 °C.
Tissue preparation and in situ hybridization
Implantation sites (E9.0) and placentas (E14.5) were dissected in cold
phosphate buffered saline (PBS) and fixed overnight in 4% paraformaldehyde
(PFA) in PBS at 4 °C. After 3× rinsing in PBS, tissues went through graded
sucrose solutions (10% in PBS and 25% in PBS) before being embedded in OCT
(Tissue Tek). Ten micron sections were cut on a cryostat (Leica), mounted on
Super Frost Plus slides (VWR), and stored at −80 °C. For in situ hybridization,
sections were re-hydrated in PBS, post-fixed in 4% PFA for 10 min, treated with
proteinase K (15 μg/ml for 5 min at room temperature for E9.0 implantation sites
and 30 μg/ml for 10 min at room temperature for E14.5 placentas), acetylated for
10 min (acetic anhydride, 0.25%; Sigma), and hybridized with digoxigenin-
labeled probes overnight at 65 °C. Digoxigenin labeling was done according to
the manufacturers instructions (Roche). Hybridization buffer contained 1× salts
(200 mM sodium choride, 13 mM tris, 5 mM sodium phosphate monobasic,
5 mM sodium phosphate dibasic, 5 mM EDTA), 50% formamide, 10% dextran
sulfate, 1 mg/ml yeast tRNA (Roche), 1× Denhardt's (1% w/v bovine serum
albumin, 1% w/v Ficoll, 1% w/v polyvinylpyrrolidone), and DIG-labeled probe
(final dilution of 1:2000 from reaction with 1 μg template DNA). Two 65 °C
post-hybridization washes were carried out (1× SSC, 50% formamide, 0.1%
tween-20) followed by two RTwashes in 1× MABT (150 mM sodium chloride,
100 mM maleic acid, 0.1% tween-20, pH 7.5), and 30 min RNAse treatment
(400 mM sodium chloride, 10 mM tris pH7.5, 5 mM EDTA, 20 μg/ml RNAse
A). Sections were blocked in 1× MABT, 2% blocking reagent (Roche), 20%
heat inactivated goat serum for 1 h, and incubated overnight in block with anti-
DIG antibody (Roche) at a 1:2500 dilution. After four 20 min washes in 1×
MABT, slides were rinsed in 1× NTMT (100 mMNaCl, 50 mMMgCl, 100 mM
tris pH 9.5, 0.1% tween-20) and incubated in NBT/BCIP in NTMTaccording to
the manufacturer's instructions (Promega). Slides were counterstained with
nuclear fast red, dehydrated and cleared in xylene, and mounted in cytoseal
mounting medium (VWR).
For double in situ experiments on TS cell cultures, the same protocol was
carried out with minor modifications. Cells were fixed in 4% PFA for 15 min and
were not proteinase K treated. Also, probes were labeled with fluorescein as well
as digoxigenin according to the manufacturer's instructions and added to the
hybridization mix. After the digoxigenin probe was detected with NBT/BCIP,
the enzyme was inactivated with heating to 65 °C for 30 min in 1× MABT,
followed by 30 min incubation in 0.1 M glycine pH 2.2, blocked for 1 h in
blocking solution and incubated overnight at 4 °C with anti-fluorescein antibody
(Roche, 1:2500). Fluorescein probes were detected by incubation with INT/
BCIP (Roche) until a brown precipitate formed. Reactions were stopped in PBS,
counterstained with nuclear fast red, and mounted under 50% glycerol/PBS for
microscopy.
β-Galactosidase and alkaline phosphatase staining
β-Galactosidase and alkaline phosphatase staining was carried out as
previously described (Lobe et al., 1999). Briefly, placentas were fixed in 2%
PFA/0.2% glutaraldehyde for 4 h with rocking (bisected after the first hour) and
processed through a series of sucrose gradients and embedded in OCT (Tissue
Tek). Ten microgram cryosections were then stained for either β-galactosidase
or alkaline phosphatase activity using NBT/BCIP (Roche) as a substrate for
β-galactosidase or INT/BCIP (Roche) as a substrate for human alkaline
phosphatase as previously described (Lobe et al., 1999). For double staining on
the same section, β-galactosidase staining was done first because detection of
human alkaline phosphatase activity driven from the transgene required a 30 min
heat inactivation of endogenous alkaline phosphatase activity, and this stepinactivates β-galactosidase activity. Counterstaining was done with nuclear fast
red and mounting was done using 50% glycerol/PBS.
Nuclear area and estimation of DNA content
Fluorescent in situ hybridizations were done on 10 μm cryosections of E14.5
placentas with probes for Plf and Pl2 as described above with the following
modifications. Detection of the digoxigenin labeled probes was done with
horseradish peroxidase conjugated anti-DIG antibodies (Roche, 1:2500)
followed by amplification with fluorescein or TMR conjugated tyramide
(Perkin Elmer). Nuclei were counterstained with DAPI. Nuclear area and DNA
content of Plf + or Pl2+ TGCs were estimated using OpenLab software
(Improvision). As a control (representing 2C nuclei), Plf −/Pl2− endothelial cell
nuclei or syncytiotrophoblast nuclei were also quantified. Statistical significance
was evaluated using a one-way ANOVA.
Results
Expression of genes from the prolactin/placental lactogen and
cathepsin gene families can distinguish TGC subtypes
In the course of using various molecular markers to
characterize the different trophoblast cell subtypes within the
mouse placenta, we focused on four that emerged as important
ones for distinguishing different cell phenotypes (Pl1, Pl2, Plf,
and Ctsq) (Fig. 1A). Plf expression was detected early in
gestation, beginning at E6.5, in TGCs that line the wall of
the implantation site separating the ectoplacental cone from
the maternal decidua, herein referred to as “parietal TGCs” or
P-TGCs (Fig. 1B, data not shown). Later in gestation, Plf
expression was also detected in the trophoblast cells lining the
spiral arteries (SpA-TGCs) and canal spaces (C-TGCs) (Figs.
1F, J, N), which result from the coalescence of the spiral arteries
(Fig. 1A). Plf expression was not detectable within the labyrinth
layer of the placenta (Fig. 1R) although scattered staining could
be seen in the spongiotrophoblast layer (Fig. 1F). Similar to Plf,
Pl1 expression could be detected early in gestation in P-TGCs
(Fig. 1C) and was absent from the labyrinth (Fig. 1S). However,
unlike Plf, Pl1 expression was not detected in SpA-TGCs (Fig.
1K) or C-TGCs (Fig. 1O) and expression was not maintained in
P-TGCs past E10.5 (Fig. 2). Pl2 expression was not detected
until ∼E9.5 and was observed in P-TGCs and spongiotropho-
blast (Figs. 1D and 2, data not shown). Pl2 expression was not
detected in SpA-TGCs (Fig. 1L). In the mature placenta, Pl2
expression was detected in P-TGCs, spongiotrophoblast (Fig.
1H), C-TGCs (Fig. 1L), and cells within the labyrinth layer (Fig.
1T). Pl2 expression within the labyrinth was restricted to the
mononuclear trophoblast cells which line the maternal sinusoids
(Fig. 1T) (Simmons and Cross, 2005). Ctsq was expressed
exclusively in these Pl2+ mononuclear trophoblast cells lining
the maternal sinusoids (Figs. 1E, I, M, Q, U), cells we will refer
to as sinusoidal TGCs (S-TGCs). Ctsq expression was not
detectable before ∼E11.5 (Figs. 1E and 2) but was evident until
the end of gestation (Fig. 2). Based on these observations, four
distinct TGC subtypes could be identified using gene expres-
sion patterns and spatial location; Pl1 and Ctsq exclusively
marked P-TGCs and S-TGCs, respectively. SpA-TGCs were
identified by expression of Plf alone and C-TGCs by expression
of both Plf and Pl2, but not Pl1 or Ctsq.
Fig. 1. Expression of genes from the prolactin and cathepsin gene families define subsets of trophoblast giant cells. (A) Diagram depicting the structures and cell types
of the murine placenta. (B–U) In situ hybridization for Pl1 (B, F, J, N, R), Pl2 (C, G, K, O, S), Plf (D, H, L, P, T), and Ctsq (E, I, M, Q, U) on E9.0 implantation sites
(B–E) and E14.5 placentas (F–U). TGCs lining the implantation site, separating the maternal decidua from the ectoplacental cone (and later the spongiotrophoblast
layer), P-TGCs (B-E), express Pl1, Plf, and Pl2 (after E9.5, not shown), but not Ctsq. Spiral artery-associated TGCs, SpA-TGCs, express Plf exclusively. Maternal
canal-associated TGCs, C-TGCs, express both Pl2 and Plf but do not express Pl1 or Ctsq. TGCs within the labyrinth layer, S-TGC, express both Pl2 and Ctsq but not
Pl1 or Plf. C—canal lumen, SpA—spiral artery lumen, *—SpA-TGC, black arrow head—C-TGC, black arrows—S-TGC.
570 D.G. Simmons et al. / Developmental Biology 304 (2007) 567–578
Fig. 2. Temporal expression of trophoblast giant cell subtype markers. Northern
blot analysis was performed using probes for Pl1, Pl2, Plf, and Ctsq and RNA
from isolated ectoplacental cone/chorion tissue (E8.5–9.5) and placentas
(E10.5–18.5).
Fig. 3. Trophoblast giant cell subtypes are polyploid. (A) SpA-TGCs, C-TGCs,
and STGCs have significantly larger nuclei at E14.5 than endothelial or
syncytiotrophoblast cells (p<0.001). P-TGCs have significantly larger nuclei
than SpA-TGC, C-TGCs, STGCs, and endothelial or syncytiotrophoblast cells
(p<0.001). (B) SpA-TGCs, C-TGCs, and S-TGCs have significantly higher
DNA content at E14.5 than endothelial or syncytiotrophoblast cells (p<0.001).
P-TGCs have significantly higher DNA content than SpA-TGC, C-TGCs, S-
TGCs, and endothelial or syncytiotrophoblast cells (p<0.001). DAPI intensity
measured in arbitrary units (AU). (C) Representative florescent in situ
hybridization of Plf (green) or Pl2 (red), indicating Plf (+) P-TGC, Plf (+)
SpA-TGC, Pl2 (+) C-TGC and Pl2 (+) S-TGC. Scale bar=0.1 mm.
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TGCs were first defined as large cells with high ploidy as a
result of endoreduplication (Gardner et al., 1973; Ilgren, 1983;
Zybina and Zybina, 1996). Therefore, nuclear size and relative
DNA content of the different TGC subtypes were measured and
compared with diploid control cells (endothelial and syncytio-
trophoblast cells of the labyrinth) in sections of E14.5 placenta.
Fluorescent in situ hybridization for Plf and Pl2 was used to
identify each TGC subtype based on a positive signal and
spatial location, and DAPI staining was used to visualize their
nuclear size and estimate DNA content (Fig. 3C). The nuclear
area of all TGC subtypes was significantly larger than that of
diploid controls (Fig. 3A, p<0.001). In addition, all TGC
subtypes had significantly higher estimated DNA content than
diploid control cells (Fig. 3B, p<0.001). Notably, P-TGCs had
larger nuclei and a higher DNA content than the other three
TGC subtypes (Figs. 3A, B, p<0.001).
All TGC subtypes appear during differentiation of trophoblast
stem cell cultures
To investigate whether all four TGC subtypes appear during
differentiation of trophoblast stem cell (TS) cultures, we first
analyzed the expression of Plf, Pl1, Pl2, and Ctsq by northern
blotting. Expression of all four genes was undetectable in stem
cells and during early differentiation. Strong expression was
detected by day 6 of differentiation (Fig. 4A). Based on in vivo
expression patterns, Pl1 and Ctsq expression indicated the
presence of P-TGCs and S-TGCs, respectively. In situ
hybridization confirmed Pl1 as well as Ctsq expressing TGCs
in day 6 differentiated cultures (Figs. 4B, D, E). In situ
hybridizations with single probes for Pl1, Pl2, Plf, or Ctsq
never showed staining in more than ∼40% of TGCs, also
suggesting that TGCs are heterogeneous in differentiating TS
cell cultures. In addition, Ctsq expressing TGCs were less
abundant in day 6 differentiated cultures than TGCs expressing
Pl1, Pl2, or Plf. To determine whether SpA-TGC or C-TGC
was present in the differentiating TS cell cultures, co-
localization was required. Dual color in situ hybridization
identified TGCs which were Plf +/Pl− (Fig. 4D), Plf +/Pl2−
(Fig. 4C), and Pl2+/Plf + (Fig. 4C). Together these observations
indicated that SpA-TGCs and C-TGCs are most likely presentin differentiating TS cell cultures as well, although triple
labeling would be required to definitively identify them.
Hand1 regulates the formation of all TGC subtypes
Previous studies have indicated a critical role for the bHLH
transcription factor Hand1 during TGC differentiation (Riley et
al., 1998; Scott et al., 2000; Hughes et al., 2004). However, the
analysis to date has been limited to what we now define as P-
TGCs because Hand1 mutants die before the time that SpA-
TGCs, C-TGCs, and S-TGCs develop. In situ hybridization
demonstrated that Hand1 was expressed in all four TGC
subtypes (Figs. 5C–F). The one exception is that Hand1
expression was not detected in SpA-TGCs that had invaded
furthest up into the spiral arteries, cells that do still express Plf,
implying that expression is lost by the distal end of their invasion
at least at E14.5 (Figs. 5A, B). To explore the functional
significance of Hand1, we assessed the expression of Plf, Pl1,
Pl2, and Ctsq in Hand1 mutant TS cells. Northern blot analysis
of differentiating Hand1−/− TS cells showed reduced expression
Fig. 4. Trophoblast giant cell subtypes appear in differentiating TS cell cultures.
(A) Northern blot analysis of Pl1, Pl2, Plf, and Ctsq mRNA expression in TS
cells over 6 days of culture in the presence (proliferating) or absence
(differentiating) of FGF, heparin, and fibroblast conditioned medium (CM).
(B) In situ hybridization of TGC subtypes in differentiating TS cell cultures (day
6 of differentiation in the absence of FGF/CM). Double in situ hybridizations
indicate Pl1+ TGCs (B, D), Pl2+ TGCs (B, C), Plf+ TGCs (C, D), Pl1/Pl2+
TGCs (B), Pl1/Plf+ TGCs (C), and Pl2/Plf+ TGCs (D). Single in situ
hybridization indicates the expression of Ctsq+ TGCs (E). Scale bar=0.1 mm.
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(Fig. 5G), indicating that loss ofHand1 impairs the formation of
all TGCs regardless of subtype. In addition, the expression
patterns for the trophoblast stem cell markers Esrrb and Eomes
(Fig. 5G) were not altered in differentiating Hand1 mutant TS
cells when compared with control.
Retinoic acid has differential effects on TGC subtype
differentiation
Retinoic acid (RA) has been shown to promote differentia-
tion of TS cells into Pl1-expressing TGCs (Yan et al., 2001;
Hemberger et al., 2004). We examined the expression of other
TGC marker genes and, strikingly, found that RA did not induce
all genes uniformly. Instead, RA-induced Pl1 and Plf only
(indicative of P-TGCs), indicating that S-TGCs and C-TGCs
were not present in these cultures (Fig. 6). As expected, RA
treatment induced TGC formation even under proliferating
conditions (in the presence of FGF4 and feeder cell conditioned
medium). Interestingly, under differentiating culture conditions(in the absence of FGF4 and feeder cell conditioned medium),
exposure to RA induced Pl1 and Plf expression but suppressed
the expression of Pl2 and Ctsq (Fig. 6). Together, these data
suggested that P-TGCs are preferentially induced by RA but
that S-TGCs are suppressed.
Not all TGC subtypes arise from Tpbpa+ precursors
It has been hypothesized that differentiation of secondary
TGCs involves intermediate steps, with cells passing through a
progenitor phase characterized by the expression of Mash2 and
Tpbpa before terminal differentiation (Carney et al., 1993;
Scott et al., 2000) and that these precursors reside within the
ectoplacental cone (and later the spongiotrophoblast layer). To
determine if all TGC subtypes originate from Tpbpa+
precursors, we took advantage of a transgenic mouse driving
Cre recombinase under the control of the Tpbpa promoter. By
crossing female Tpbpa-Cre mice with male Z/AP dual reporter
mice (Lobe et al., 1999), Cre induced the removal of the LacZ
gene encoding β-galactosidase, and therefore the subsequent
activation of human alkaline phosphatase (hAP), in all cells
that had previously or continued to express Tpbpa. Staining
for hAP activity therefore identified cells which originated
from Tpbpa+ precursors and β-galactosidase activity indicates
those cells which did not (Fig. 7A). Examination of E14.5
placentas indicated that none of the S-TGCs in the labyrinth
layer expressed hAP (Figs. 7B, F, J, N and 8). In contrast,
virtually all SpA-TGCs observed were positive for hAP (Figs.
7D, H, L, P and 8). Interestingly, the origins of P-TGCs (Figs.
7C, G, K, O) and C-TGCs (Figs. 7E, I, M, Q) were mixed,
with approximately half of each subtype originating from
Tpbpa+ precursors (Fig. 8). Based on these data, TGC
subtypes had different developmental origins. In addition,
TGCs of the same subtype could also have different
developmental origins.
Discussion
While a few studies have previously described heterogeneity
in gene expression within TGCs (Weiler-Guettler et al., 1996;
Hunter et al., 1999; Hemberger et al., 2000; Ma and Linzer,
2000), most have generally regarded TGCs as a homogeneous
single cell population that lines the implantation site. These
cells, what we now call parietal TGCs (P-TGCs), form the
barrier between the maternal decidua and the ectoplacental cone
and later the spongiotrophoblast layer. We have demonstrated
the existence of additional TGC subtypes within the mature
placenta. The four different TGC subtypes we have described
are all postmitotic and polyploid, but can be distinguished by
differential location, gene expression, cell lineage origins, and
regulation of differentiation (Fig. 9). Endovascular trophoblast
cells have previously been implied based on the expression of
Plf (Adamson et al., 2002; Hemberger et al., 2003), but we
have expanded this to now show that these cells are indeed
polyploid. Pl2 expressing cells have been identified in the
mouse and rat labyrinth layer, but they have not previously been
confirmed to be TGCs (Campbell et al., 1989; Deb et al., 1991;
Fig. 5. Hand1 mRNA is expressed in all trophoblast giant cell subtypes and regulates trophoblast giant cell differentiation. Hand1 expression can be detected in all
four trophoblast giant cell subtypes (C–F). Hand1 expression is detected in SpA-TGCs proximal to the placenta (C) but appears absent from more distal SpA-TGCs
(A) which still express Plf (B). Hand1 mutant TS cells show reduced expression of marker genes for all TGC subtypes in vitro, but do not have altered expression of
the TS cell markers Err2 and Eomes (G). C—canal lumen, SpA—spiral artery lumen. Scale bar=0.1 mm.
573D.G. Simmons et al. / Developmental Biology 304 (2007) 567–578Dai et al., 2000; Sahgal et al., 2000; Lee et al., 2003; Ishida et
al., 2004; Simmons and Cross, 2005), though a recent study
showed that the mononuclear trophoblast cells in the labyrinth
are indeed polyploid (Coan et al., 2005). We have brought these
different observations together and added significant new
details. With this knowledge, and the availability of new
markers, mouse mutants with placental phenotypes can now be
described in greater detail. More importantly, the discovery of
several new TGC subtypes, some with overlapping patterns of
hormone gene expression, raises significant questions about the
functions of these cells.Fig. 6. Formation of trophoblast giant cell subtypes is differentially regulated by retin
trophoblast giant cell formation in TS cell cultures, even in the presence of FGF and
trophoblast giant cell subtypes are uniformly up-regulated (compare with marker pr
TGCs. * Indicates TS cell morphology and arrowhead indicates TGC morphology.The TGC subtypes that we have identified have distinct
patterns of gene expression, although only two have exclu-
sive markers. Pl1 is unique to P-TGCs and Ctsq is unique to
S-TGCs. For the other subtypes, we have not yet identified cell
subtype-specific genes. In addition, some genes are expressed in
multiple subtypes. For example, Plf is expressed in SpA-TGCs,
P-TGCs, and C-TGCs while Pl2 is expressed in P-TGCs,
C-TGCs, and S-TGCs. Distinct patterns of gene expression not
only serve to identify TGC subtypes, but also indicate different
programs of differentiation. Previous studies have shown that
Pl1 expression precedes Pl2 in P-TGCs (Carney et al., 1993).oic acid. Northern blot analysis demonstrates that retinoic acid (RA) can induce
embryonic fibroblast conditioned medium (CM). However, not all markers of
ofile of control) indicating preferential induction of P-TGCs and possibly SpA-
Scale bar=0.1 mm.
Fig. 7. Not all trophoblast giant cells arise from Tpbpa+ precursors. Female mice carrying a transgene containing a Cre recombinase-IRES-EGFP cassette under the
control of the Tpbpa promoter were crossed with male Z/AP reporter mice to trace the fate of ectoplacental cone/spongiotrophoblast precursors. Placentas were stained
at E14.5 for either β-galactosidase (blue) and/or human alkaline phosphatase (brown). Almost all SpA-TGCs arise from Tpbpa (+) precursors (D, H, L, P) while none
of the S-TGCs do (B, F, J, N). P-TGC (C, G, K, O) and C-TGCs (E, I, M, Q) appear to arise from either Tpbpa (+) precursors or Tpbpa (−) precursors.
574 D.G. Simmons et al. / Developmental Biology 304 (2007) 567–578However, Pl1 expression is not detectable in the developing
labyrinth layer, and therefore Pl2 expression in S-TGCs
appears without first going through a transient Pl1 expressing
stage. In addition, SpA-TGCs turn off Pl1 expression before
P-TGCs and, unlike P-TGCs, never express Pl2. These
observations indicate a unique differentiation program for
each TGC subtype.
The results of our study have not only added new cell
types, but have indicated a need to revise the past model of
how the trophoblast cell lineage develops into the various
differentiated cell types. Previously, the P-TGC population
was thought to arise both from the mural trophectoderm and
from the secondary differentiation of precursors in theectoplacental cone and later the spongiotrophoblast layer
(Rossant and Ofer, 1977; Johnson and Rossant, 1981; Carney
et al., 1993). Our results have indicated, however, that ∼50%
of P-TGCs in the midgestation placenta are derived from
Tpbpa− cells. There are only ∼50 mural trophectoderm cells
that could form the primary wave of P-TGCs and yet there are
several hundred P-TGCs lining the implantation site by E8.5
(Scott et al., 2000). As a result, there must be an additional
source of secondary P-TGCs in addition to Tpbpa+ precursors
of the ectoplacental cone, perhaps even from outside the
ectoplacental cone/spongiotrophoblast. The caveat with the
strict interpretation of the cell numbers is that when using Cre-
mediated transgene activation, there may be some delay
Fig. 8. Different trophoblast giant cell subtypes have different developmental
origins. Quantification of trophoblast giant cell subtypes originating from
Tpbpa (+) (hPLAP positive—brown) versus Tpbpa (−) (β-galactosidase
positive—blue) precursors. Error bars=±S.E.M.
575D.G. Simmons et al. / Developmental Biology 304 (2007) 567–578between the onset of Cre expression and detection of the hAP
activity (Nagy, 2000). We previously addressed this possibility
by looking at whether there are cells in the spongiotrophoblast
layer that express Tpbpa mRNA but which do not also express
hPLAP, but we found a perfect congruence (A. Fortier et al.,
unpublished). We have also found that the Cre transgene
begins expression and has associated recombinase activity as
early as E8.5. Therefore, if there is a delay, it probably is not
significant and though may account for some unlabeled cells,
it is unlikely to account for the hundreds of P-TGCs that
cannot be accounted for by mural trophectoderm precursors
alone.
The potential additional source of P-TGCs is either the direct
differentiation of trophoblast stem cells into P-TGCs or
differentiation from a previously uncharacterized precursor
population in the ectoplacental cone that is devoid of Tpbpa
expression. Previous studies have shown that retinoic acid
treatment of TS cell cultures can induce TGC differentiation
(based on morphology and Pl1 expression) without first
expressing Tpbpa/4311 (Yan et al., 2001), clearly suggesting
an alternative pathway of TGC differentiation. Our observations
show that the type of TGC produced by RA treatment is
specifically the P-TGC subtype. Tpbpa expression at E8.5,
when expression is initiated, does not encompass the chorion or
even the whole of the ectoplacental cone, particularly at the base
of the ectoplacental cone nearest the chorion. Therefore, it is
possible that P-TGC precursors reside in this area.
The origin of the other TGC subtypes is specific to each
subtype. In contrast to P-TGCs, virtually all of the SpA-TGCs
we observed expressed hPLAP, indicating their origin from
Tpbpa+ precursors. This makes some sense as the ectoplacental
cone is oriented to grow towards the incoming spiral arteries. In
contrast, none of the S-TGCs was positive for hPLAP
indicating an alternative developmental origin. As Tpbpa
expression does not encompass the whole of the ectoplacental
cone, particularly at the base closest to the chorion, it seems
likely that S-TGC cells arise from precursors either within the
Tpbpa− area of the ectoplacental cone or from chorion
trophoblast directly. The different origins of SpA-TGCs and
S-TGCs are not surprising considering the spatial localization
of the two subtypes in the mature placenta. C-TGCs have
mixed developmental origins, with approximately half arising
from Tpbpa+ precursors, similar to the findings with P-TGCs.
Interestingly, hPLAP+ C-TGCs cells are intermixed with β-galactosidase+ C-TGCs cells along the entire length of the
canals, with no clear demarcations.
The ability to culture trophoblast stem (TS) cells has been
invaluable for the study of trophoblast differentiation and TGC
formation in particular. In this system, FGF, heparin, and
embryonic fibroblast conditioned medium is required to
maintain proliferating conditions and promote TS cell self-
renewal (Tanaka et al., 1998). Given the obvious utility of this
system for the study of TGC differentiation, we used markers
for Plf, Pl1, Pl2, and Ctsq which can distinguish TGC subtypes
in vivo to probe northern blots of differentiating TS cell cul-
tures. All four markers were induced by day 6 of differentiation,
indicating the presence of multiple TGC subtypes within the
culture system.
TGC formation relies on the interplay of numerous cell
intrinsic factors to guide proper differentiation, most notably
basic helix–loop–helix (bHLH) transcription factors and their
interacting partners including Hand1, Mash2, Alf1, Itf2, Id1/2,
and I-mfa (Cross et al., 1995; Jen et al., 1997; Kraut et al.,
1998; Riley et al., 1998; Scott et al., 2000; Hughes et al., 2004).
Hand1 in particular is essential for proper TGC differentiation
as Hand1 deficient conceptuses die by E7.5 due to a block in
TGC formation (Riley et al., 1998; Scott et al., 2000). Results
of the current study indicated that Hand1 is expressed in all
four TGC subtypes and also that it regulates the differentiation
of all TGC subtypes. Expression of all the various TGC
subtype markers was significantly impaired in differentiating
Hand1 mutant TS cell cultures (Fig. 5G). The ability of the
cells to begin to differentiate in general was not affected in
these cells as indicated by the correct downregulation of the
trophoblast stem cell markers Esrrb and Eomes. Differentiated
Hand1 mutant TS cells have previously been shown to contain
significantly fewer invasive TGCs, demonstrating an intrinsic
deficiency in TGC formation (Hemberger et al., 2004). In vivo,
Hand1 is required both for differentiation of mural trophecto-
derm into TGCs and to promote secondary TGC differentiation
(Riley et al., 1998; Scott et al., 2000). It would be of obvious
interest to see whether other cell intrinsic and paracrine factors
known to regulate P-TGC differentiation are also required for
differentiation of other TGC subtypes. Retinoic acid treatment
did not induce Pl2 or Ctsq expression, and in fact suppressed
the induction of these markers under differentiating conditions,
indicating that retinoic acid promotes P-TGCs (and possibly
SpA-TGCs also) but not C-TGCs or S-TGCs. These differ-
ential effects imply that while there are some common features,
the different TGC subtypes are also regulated by their own
mechanisms.
The existence of numerous TGC subtypes with unique gene
expression patterns and spatial localization begs the question,
what is the functional significance of having multiple TGC
subtypes? One could speculate that the specific milieu of
hormones and growth factors produced by each TGC subtype
would have particular functions intimately tied to their location
within the placenta. For example, SpA-TGCs are known to
secrete factors which regulate blood flow to the implantation
site such as vasodilators and angiogenic factors. Proliferin
(Plf), an angiogenic factor known to stimulate endothelial cell
Fig. 9. Summary of the trophoblast cell lineage and origins of different TGC subtypes.
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(Plfr), an anti-angiogenic factor (Jackson et al., 1994), are both
expressed in SpA-TGCs. The combination of hormones and
cytokines secreted by P-TGCs may preferentially target
decidual cells or infiltrating leukocytes such as natural killer
cells. Prlpa is expressed predominantly by P-TGCs (Ma and
Linzer, 2000) and has been shown to modulate uterine natural
killer cells (Muller et al., 1999; Ain et al., 2003). S-TGCs,
located within the labyrinth layer closest to the fetal
circulation, are well situated to facilitate delivery of hormones
and/or cytokines into the fetal circulation or to produce
molecules which effectively clear, or modulate the bioactivity,
of hormones before they enter the fetal circulation. This could
potentially be an important function for Ctsq, a protease
uniquely expressed in S-TGC, as it has been hypothesized to
cleave members of the prolactin-like protein family such as
Pl2 (Ishida et al., 2004). Cleavage of prolactin, itself an
angiogenic factor, by cathepsin D for example, results in a
shorter fragment with anti-angiogenic activity (Struman et al.,
1999; Lkhider et al., 2004; Piwnica et al., 2004). The potential
cleavage of other members of the prolactin family locus, of
which there are at least 23 known to be expressed within the
placenta (Wiemers et al., 2003), possibly by placentally
expressed cathepsins, may prove to be a critical regulatory
system within the placenta to augment hormone bioactivity
before entering the fetal circulation or re-entering the maternal
circulation.
Some genes have multiple sites of expression, such as Pl2
and Plf. However, the biological action of these gene products
likely depends on the local environment they are secreted into,
with different TGC subtypes using the same molecule to
different ends. For example, Plf can stimulate angiogenesis and
endothelial cell migration (Jackson et al., 1994), a function
required in the immediate vicinity of SpA-TGCs. But Plf
secretion from P-TGCs may be critical for stimulating uterine
cell proliferation (Nelson et al., 1995), something which occurswidely within the decidua bordering P-TGCs. Likewise, Pl2 is
expressed in multiple TGC subtypes and is known to act
through the prolactin receptor to regulate maternal adaptations
to pregnancy such as mammary gland development and corpus
luteum maintenance (Soares, 2004) or to bind receptors in fetal
liver, pancreas, kidney, and intestine influencing fetal develop-
ment (Freemark et al., 1993). TGC subtype-specific expression
may determine which compartment, fetal or maternal, is
targeted. Pl2 is expressed early in gestation from P-TGCs,
when maternal Pl2 serum levels are high and in the second half
of gestation from S-TGCs when Pl2 first appears in the fetal
circulation (Kishi et al., 1991).
In conclusion, the present study demonstrates a previously
underappreciated level of TGC sub-specialization and provides
a panel of markers which allows for the identification of at least
four TGC subtypes. In addition, cell lineage tracing studies
show that TGC subtypes can have different developmental
origins, and even TGCs of the same subtype can have more than
one developmental origin. There are likely more subtypes to be
idenified as a number of genes expressed in P-TGCs, for
example, are not uniformly expressed within this population,
including Mrj (Hunter et al., 1999), Thrombomodulin (Weiler-
Guettler et al., 1996), and members of the Cathepsin family
(Hemberger et al., 2000). In addition, Ma and Linzer describe
Prlpa expression in secondary TGCs but not in primary
TGCs, adding a marker distinguishing TGCs from these two
different trophectoderm lineages (Ma and Linzer, 2000). Studies
investigating trophoblast differentiation or mutant mice with
placental phenotypes have often relied on the expression of just
a few TGC markers, particularly Pl1, Pl2, or Plf, as a read out
of TGC formation and function. In light of our findings, we now
know that expression of these specific genes does not reflect the
whole of the TGC population. Clearly, future studies of tro-
phoblast differentiation or gene targeted mice with placental
phenotypes should account for the diversity of trophoblast
subtypes.
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